Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1338-1344

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nenseter, M. S.
Right arrow Articles by Drevon, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nenseter, M. S.
Right arrow Articles by Drevon, C. A.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1338-1344.)
© 1995 American Heart Association, Inc.


Articles

Paracetamol Inhibits Copper Ion–Induced, Azo Compound–Initiated, and Mononuclear Cell–Mediated Oxidative Modification of LDL

Marit S. Nenseter; Bente Halvorsen; Øyvind Rosvold; Arild C. Rustan; Christian A. Drevon

From the Institute for Nutrition Research (M.S.N., B.H., C.A.D.) and the Department of Pharmacology, Institute of Pharmacy (Ø.R., A.C.R.), University of Oslo, Oslo, Norway.

Correspondence to Marit S. Nenseter, Institute for Nutrition Research, University of Oslo, PO Box 1046, Blindern, 0316 Oslo, Norway. E-mail marit.nenseter@basalmed.uio.no.

Abstract The effects of paracetamol and sodium salicylate on the susceptibility of LDL to oxidative modification were studied. LDL was subjected to Cu2+-, azo compound–, or peripheral blood mononuclear cell–initiated oxidation in the absence and presence of paracetamol and salicylate. Paracetamol (100 µmol/L; 25 µg LDL/mL) reduced the rate of formation of conjugated dienes and the amount of conjugated dienes formed during Cu2+-induced oxidation by 67% and 58%, respectively. Paracetamol (400 µmol/L; 100 µg LDL/mL) reduced the generation of lipid peroxides during Cu2+-induced oxidation by 43% (P<.05), the relative electrophoretic mobility in agarose gels by 16% (P<.05), and the amount of oxidized LDL taken up by J774 macrophages by 22% (P<.05). Paracetamol (100 µmol/L; 100 µg LDL/mL) reduced the 2,2'-azobis-(2-amidinopropane hydrochloride)–initiated lipid peroxidation by 70% (P<.05) and the relative electrophoretic mobility by 34% (P<.05). Paracetamol (100 µmol/L; 100 µg LDL/mL) reduced the amount of lipid peroxides generated in LDL during mononuclear cell–mediated oxidation by 69% (P<.01) and the relative electrophoretic mobility by 38% (P<.01). In comparison, 10 µmol/L {alpha}-tocopherol reduced the amount of lipid peroxides formed during cellular LDL oxidation and the relative electrophoretic mobility by 52% and 65%, respectively (P<.05). In the absence of paracetamol, SOD and catalase inhibited the modification of LDL (P<.05), suggesting that superoxide anions and hydrogen peroxide might be involved in the cell-mediated modification pathway. In the presence of paracetamol, SOD showed no additional inhibitory effect. The 1,1-diphenyl-2-pikrylhydracyl radical–scavenging test showed that paracetamol itself was a free-radical scavenger. In contrast, sodium salicylate (25 to 4000 µmol/L) showed no free radical–scavenging property and failed to protect LDL against mononuclear cell–mediated oxidation. In conclusion, the results indicate that paracetamol, but not salicylate, protects LDL against Cu2+-induced, azo compound–initiated, and mononuclear cell–mediated oxidative modification in vitro and that this may be due to the radical scavenger capacity of paracetamol.


Key Words: oxidized LDL • lipid peroxidation • atherosclerosis • acetylsalicylic acid • acetaminophen




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
R. Golfetti, T. Rork, and G. Merrill
Chronically Administered Acetaminophen and the Ischemia/Reperfused Myocardium
Experimental Biology and Medicine, June 1, 2003; 228(6): 674 - 682.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. R. Brude, C. A. Drevon, I. Hjermann, I. Seljeflot, S. Lund-Katz, K. Saarem, B. Sandstad, K. Solvoll, B. Halvorsen, H. Arnesen, et al.
Peroxidation of LDL From Combined-Hyperlipidemic Male Smokers Supplied With Ż-3 Fatty Acids and Antioxidants
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2576 - 2588.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Kapiotis, G. Sengoelge, M. Hermann, I. Held, C. Seelos, and B. M. K. Gmeiner
Paracetamol Catalyzes Myeloperoxidase-Initiated Lipid Oxidation in LDL
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2855 - 2860.
[Abstract] [Full Text]